Search research articles
Contact Us
Filters
Showing results (51-60 of 127) with videos related to
Page
of 13
Sort By:
Toxicon : Official Journal of the International Society on Toxinology
|
May 1, 2020
BmK NSP, a new sodium channel activator from Buthus martensii Karsch, promotes neurite outgrowth in primary cultured spinal cord neurons
Xiaohan Zou, Yujing Wang, Yiyi Yu, et al.
Experimental Cell Research
|
July 15, 2021
Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers
Shan Yu, Qian Li, Yan Wang, et al.
Journal of Cancer Research and Clinical Oncology
|
November 1, 2019
A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy
Qian Li, Minzhi Lv, Huiqin Jiang, et al.
Journal of Proteome Research
|
March 20, 2025
Global Profiling of Lactylation Proteomics and Specific Lactylated Site Validation in Rheumatoid Arthritis Patients
Jiaqi Hu, Zhengyi Jin, Ying Gao, et al.
Cancer Management and Research
|
November 11, 2020
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
Wei Li, Qian Li, Yiyi Yu, et al.
Annals of Translational Medicine
|
May 13, 2020
IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis
Qian Li, Ke Peng, Erbao Chen, et al.
Medical Oncology (Northwood, London, England)
|
August 14, 2015
Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma
Mengzhou Guo, Yiyi Yu, Yan Wang, et al.
Oncology Letters
|
January 25, 2019
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
Xiaojing Xu, Hong Li, Ke Peng, et al.
Critical Reviews in Oncology/Hematology
|
September 8, 2024
Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment
Mengling Liu, Qing Liu, Keshu Hu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
September 6, 2016
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy
Zhiming Wang, Li Liang, Yiyi Yu, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 127) with videos related to
Sort By:
Page
of 13
Toxicon : Official Journal of the International Society on Toxinology
|
May 1, 2020
BmK NSP, a new sodium channel activator from Buthus martensii Karsch, promotes neurite outgrowth in primary cultured spinal cord neurons
Xiaohan Zou, Yujing Wang, Yiyi Yu, et al.
Experimental Cell Research
|
July 15, 2021
Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers
Shan Yu, Qian Li, Yan Wang, et al.
Journal of Cancer Research and Clinical Oncology
|
November 1, 2019
A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy
Qian Li, Minzhi Lv, Huiqin Jiang, et al.
Journal of Proteome Research
|
March 20, 2025
Global Profiling of Lactylation Proteomics and Specific Lactylated Site Validation in Rheumatoid Arthritis Patients
Jiaqi Hu, Zhengyi Jin, Ying Gao, et al.
Cancer Management and Research
|
November 11, 2020
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
Wei Li, Qian Li, Yiyi Yu, et al.
Annals of Translational Medicine
|
May 13, 2020
IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis
Qian Li, Ke Peng, Erbao Chen, et al.
Medical Oncology (Northwood, London, England)
|
August 14, 2015
Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma
Mengzhou Guo, Yiyi Yu, Yan Wang, et al.
Oncology Letters
|
January 25, 2019
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
Xiaojing Xu, Hong Li, Ke Peng, et al.
Critical Reviews in Oncology/Hematology
|
September 8, 2024
Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment
Mengling Liu, Qing Liu, Keshu Hu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
September 6, 2016
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy
Zhiming Wang, Li Liang, Yiyi Yu, et al.
Page
of 13